This Government Contract opportunity from Department Of Defense was posted on May 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Twist Bioscience Reagent Kits and Components

Awarded

1301374127Federal

Submission Closed06/01/2026, 08:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714

New

Federal

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_NPIVS_27

BARDA is seeking contractors to support the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The selected providers will be responsible for furnishing all necessary personnel, materials, and facilities to produce vaccines, antigens, and adjuvants for pandemic preparedness and public health emergencies. This includes generating and submitting critical analytical, clinical, and manufacturing data to the FDA to ensure rapid regulatory decisions and manufacturing readiness. To be eligible for this award, offerors must have experience producing vaccines against influenza and strains with pandemic potential. Mandatory qualifications include either holding a U.S. influenza vaccine license or demonstrating the development of an influenza vaccine through the submission of a Biologics License Application for seasonal or pandemic vaccines. This solicitation is managed by the Department of Health and Human Services with a response deadline of October 30, 2026.

Barda - Aspr / Daappo / Barda Dcma

POSTED

DEADLINE

Industry Day: DARPA Documentation & Decision Support Sprint (D2)

Solicitation # DARPA-SN-26-118

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

DARPA Surgical Competition (DSC) Industry Day

Solicitation # DARPA-SN-26-125

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Human Hindbrain Organoid Functional Assay Services.

Solicitation # RFQ_CDR-2026-135968

The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Hypoxia Chamber Services

Solicitation # 80JSC026Q0008

NASA Johnson Space Center is soliciting combined synopsis and request for quotations under solicitation 80JSC026Q0008 for Hypoxia Chamber Services to support the Artemis Program. The objective is to investigate the physiological, cognitive, and clinical effects of mild hypobaric hypoxia through two 7-day test protocols involving continuous habitation for six subjects at air equivalent altitudes of 7,000 and 9,500 feet. The scope of work encompasses the provision of infrastructure, personnel, training, materials, and operational support. The contract is structured as a firm fixed price agreement with a base period from September 15, 2026, to September 30, 2027, and multiple option periods extending through March 1, 2030. The acquisition is open to all responsible sources under NAICS code 541714, with a size standard of 1,000 employees. Evaluation is based on a trade-off process where technical acceptability and past performance are significantly more important than price. Proposals must be submitted via email to the designated points of contact by October 1, 2026, following an extension granted in Amendment 0004. Key requirements include the submission of FAR 52.212-3 representations and certifications and adherence to specific submission criteria regarding team qualifications and risk assessment. The contract also incorporates strict guidelines regarding the protection of sensitive information and restrictions on funding activities with China.

NASA Johnson Space Center

POSTED

DEADLINE

Hypobaric Chamber Pilot Studies

Solicitation # 80JSC026Q0006

NASA Johnson Space Center is soliciting quotes under solicitation 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity to support Artemis mission planning. The base requirement consists of three test days, with a minimum of two subjects per day, collecting and recording data according to research protocols. The contract also includes six optional work items, including additional test days, inflight-like treatment preparation, elevated metabolic rate testing, pharmaceutical-enhanced prebreathe, and body temperature studies. The base period of performance runs from September 1, 2026, to September 30, 2027, with various option periods extending through March or September 2029. This is a small business set-aside acquisition under NAICS code 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule for subject throughput. Offerors must provide a price quotation using the provided pricing sheet, and quotes must remain valid for at least 90 days. Following several amendments, the final deadline for the submission of offers is October 1, 2026, at 1:00 p.m. Central Time. All submissions must be sent electronically to the designated points of contact.

NASA Johnson Space Center

POSTED

DEADLINE

Undiagnosed Diseases Network (UDN) Diagnostic Research Innovation CenterThe National Institutes of Health, through the NINDS, is forecasting the establishment of a Diagnostic Research Innovation Center to support the next phase of the Undiagnosed Diseases Network. This center will operate as part of a broader ecosystem including the Clinical and Data Coordinating Center, Networks of Diagnostic Excellence, and the NIH Undiagnosed Diseases Program. The primary objective of the center is to advance innovative diagnostic tools and strategies for both genomic and non-genomic conditions, which includes the systematic re-evaluation of unsolved cases from previous network phases. The center will focus on generating and testing diagnostic hypotheses by utilizing advanced sequencing, multi-omics, and gene function studies in animal and human in vitro models. By collaborating with various network stakeholders, the center aims to identify novel disease-associated genes, genomic variants, and new syndromes. This initiative seeks an integrated center featuring investigators with a history of scientific synergy and collaboration. While this is currently a forecast to allow potential applicants time to plan and establish partnerships, formal applications are not yet being solicited.

National Institutes Of Health

POSTED

DEADLINE

study entitled “Malaria and vector borne disease surveillance in the Colombia/Venezuela border”

Solicitation # ERP_1301373256

The Naval Medical Research Unit South in Lima, Peru, is seeking a provider to conduct a study focused on malaria and vector borne disease surveillance along the Colombia and Venezuela border. While the government has identified the Administrators of Tulane Educational Fund as the only vendor currently capable of supporting the entire requirement, they are issuing this notice to identify other capable sources before proceeding with a sole source award under FAR 13.106-1(b)(i). Interested parties must submit a capability statement including technical, management, and cost data to Genaro Vasquez via email by 12:00 PM local time on September 18, 2026. Submissions must be in Microsoft Word or PDF format, not exceed five pages, and use the subject line ERP_1301373256. The government will use these submissions to determine whether to pursue a competitive procurement or move forward with the intended sole source contract.

Naval Medical Research Center

POSTED

DEADLINE

Cryo-Electron Microscopy (Cryo-EM) Services

Solicitation # 75N98026Q01177

The National Institutes of Health Olao, under the Department of Health and Human Services, is seeking providers for Cryo-Electron Microscopy (Cryo-EM) Services under solicitation number 75N98026Q01177. This combined contract opportunity is categorized under NAICS code 541714 and is managed by the office located in Bethesda, Maryland. Interested parties must submit their responses by the deadline of September 16, 2026, at 6:00 PM. The primary point of contact for this procurement is Roxane S. Burkett.

National Institutes Of Health Olao

POSTED

DEADLINE

TIDAL: Target-Induced Droplet Assembly of Ligands

Solicitation # S-197478

Developed by Los Alamos National Laboratory, TIDAL (Target-Induced Droplet Assembly of Ligands) is a programmable protein-only material that utilizes nanobodies fused with encapsulation peptides to create dynamic, liquid-like droplets through phase separation. This technology allows for the precise concentration of binders upon encountering a target ligand, enabling a versatile platform for resin-free protein purification, high-sensitivity diagnostics, and the creation of slow-release drug depots. It can also function intracellularly to sequester and neutralize harmful proteins associated with viral infections or cancer. The technology is currently at TRL 3 with a patent pending and is available for exclusive or non-exclusive licensing through the Department of Energy contractor, Triad. Key market applications span biopharmaceutical manufacturing, therapeutics, and biotechnology. Interested parties can contact Caleb Ledgerwood or Lindsay Augustyn via the provided licensing email to explore commercial partnerships for this innovation.

Triad - DOE Contractor

POSTED

DEADLINE

Master Protocol Development & Adaptive Design

POSTED

DEADLINE

Phase I/II Clinical Trial Management & Execution

W6QK Acc-Apg

POSTED

8 days ago

DEADLINE

in 5 days

AI Contract Overview

The United States Department of the Naval Medical Research Command intends to award a sole source contract to Twist Bioscience of South San Francisco, CA, for specialized reagent kits essential to the detection and identification of biological warfare agents and emerging pathogens. The procurement is justified under FAR 6.302-1 due to the proprietary and platform-specific nature of Twist Bioscience’s products, which are uniquely compatible with the command’s existing molecular surveillance systems and cannot be replicated by any other vendor. The contract includes nine distinct reagent kits and components, including TrueArnp Library Preparation Kits, Universal Adapter System Plates A through D, Standard Hyb and Wash Kits with TrueArnp Mix, Universal Blockers, Dry Down Beads, and the Comprehensive Viral Research Panel, with quantities ranging from one to five units per item. The acquisition is being conducted under FAR Part 12 as a commercial item purchase, with a firm fixed-price contract structure, and does not involve competitive bidding. All offerors must be registered in the Systems for Award Management with a valid Unique Entity Identifier, and no award will be made without this registration. The place of performance is designated as Tripler Army Medical Center in Honolulu, Hawaii, where the reagents will be utilized for global emerging infections surveillance. The Naval Medical Research Command, located in Silver Spring, Maryland, is the(procuring agency, with contractual oversight provided by the Material Management Department. Technical cognizance is managed by Julia Tomasello of the Molecular Diagnostics Department, while Shamai Carter serves as the contracting officer. The solicitation was posted on May 27, 2026, with responses due by June 1, 2026, and submission must occur electronically through the Government Point of Entry. No formal evaluation factors, inspection criteria, packaging specifications, or delivery terms beyond the place of performance were specified, as the commercial nature of the items and sole-source justification eliminate the need for competitive scoring or detailed technical compliance protocols. The NAICS code assigned to this action is 541714 for Research and Development in Biotechnology. No contract value is disclosed, as pricing details are not provided, but payment will follow standard commercial practices under the firm fixed-price arrangement.

General Info

NMRC sole source contract to Twist Bioscience for biological defense reagent kits, Hawaii-based.

Agency

Department Of Defense → Naval Medical Research CenterView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Tripler Army Medical Center, HI, 96859, USA

Set-Aside

NONE

Documents

(1)

Justification and Approval for Sole Source Award Twist Bioscience Reagent Kits

PDF•justification-and-authorization

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseAwarded

PostedMay 27

special-notice

AwardedSep 12

Contract was awarded

Submission Closed

06/01/2026, 08:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Naval Medical Research Center

Contacts2 people available

OfficeSILVER SPRING, MD, 20910-7500, USA

Organization / Agency

Department Of Defense → Naval Medical Research Center

View Agency Profile

Office AddressSILVER SPRING, MD, 20910-7500, USA

Contacts

Shamai Carter

contact@example.gov

Nataki JOHNSON

contact@example.gov

Full Description

The United States Department of the Naval Medical Research Command (NMRC) intends to award a sole source contract to, Twist Bioscience, South San Francisco, CA. This notice is not a request for competitive proposals however If interested Government shall consider all responses.

NMRC's Molecular Department of the Biological Defense Research Directorate are in need for multiple Twist Bioscience Reagent kits and components which are essential for the surveillance efforts in the detection and identification of biological warfare agents and emerging pathogens. The following reagents are needed:

(1) Twist TrueArnp Library Preparation, 96 Samples; Twist TrueArnp Library Preparation Kit, 96 Samples (116481) Part Number: 116481 - QTY: 5/EA.;

(2) Twist Universal Adapter System - TruSeq Compatible, 96 Samples Plate A; Twist Universal Adapter System - TruSeq Compatible, 96 Samples Plate A (101308) Part Number: 101308 - QTY: 2/EA.;

(3) Twist Universal Adapter System - TruSeq Compatible, 96 Samples Plate B; Twist Universal Adapter System - TruSeq Compatible, 96 Samples Plate B (101309) Part Number: 101309 - QTY: 1/EA.;

(4) Twist Universal Adapter System - TruSeq Compatible, 96 Samples Plate C; Twist Universal Adapter System - TruSeq Compatible, 96 Samples Plate C (101310) Part Number: 101310 - QTY: 1/EA.;

(5) Twist Universal Adapter System - TruSeq Compatible, 96 Samples Plate D; Twist Universal Adapter System - TruSeq Compatible, 96 Samples Plate D (101311) Part Number: 101311 - QTY: 1/EA.;

(6) Twist Standard Hyb and Wash Kit v2 with TrueArnp Mix, 12 Rxns; Twist Standard Hyb and Wash Kit v2 with TrueArnp Mix, 12 Reactions (116614) Part Number: 116614 - QTY: 5/EA.;

(7) Twist Universal Blockers, 12 Reactions; Twist Universal Blocker, 12 Reactions (100578) Part Number: 100578 -QTY: 5/EA.;

(8) Twist Dry Down Beads, 12 reactions; Twist Dry Down Beads, 12 reactions (104325) Part Number: 104325 - QTY: 5/EA.; and

(9) Twist Comprehensive Viral Research Panel, 12 Reactions, Kit; Twist Comprehensive Viral Research Panel, 12 Reactions, Kit (103550) Part Number: 103550 - QTY: 5/EA.

The NAICS code for this action is 541714. This requirement will be procured under the guidelines of FAR Part 12 Commercial Items. NMRC requires that all contractors doing business with the Acquisition Office must be registered with the Systems for Award Management (SAM). No award can be made unless the vendor is registered in Systems for Award Management. For additional information and to register in SAM, please access the following website: https://www.sam.gov/. In order to register with the SAM and to be eligible to receive an award from this Acquisition Office, all offers must have a Unique Entity Identification Number (UEI). A Sam.gov number may be acquired free of charge by contacting Sam.gov online at www.sam.gov or by phone at (866) 606-8220.